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Allelic Inclusion of T Cell Receptor a Genes
Poses an Autoimmune Hazard Due to Low-Level
Expression of Autospecific Receptors
attack body tissue by the second receptor's recognition
of self-epitopes not presented by APCs and therefore
unable to activate T cells (Lanzavecchia, 1995; Zal et
al., 1996). Because of major histocompatibility complex
(MHC) restriction, the coexpression of two receptors
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able to recognize distinct epitopes presented by self-75730, Paris
MHC molecules may be an infrequent event and thusFrance
may not pose a serious threat to the organism.
Here we provide evidence for an alternative mecha-
nism, namely that autoimmunity can result from TCRaSummary
allelic inclusion irrespective of the specificity of the sec-
ond TCR. T cells expressing low levels of an autospecificOrgan-specific autoimmune disease can be caused by
TCR because of thepresence of competing TCRa chainsab T cells that have escaped self-tolerance induction.
can escape negative selection in primary and/or sec-Here we show that one of the causes of escape from
ondary lymphoid organs but can be activated and causeself-tolerance is the coexpression of two different T
autoimmune disease by antigens expressed in a tissue-cell receptors by the same cell, which can occur in up
specific fashion.to 30% of all T cells in normal mice and can lead to
low-level surface expression of an autospecific TCR.
ResultsWe found that double receptor±expressing T cells can
escape tolerance even to ubiquitously expressed anti-
Diabetes Can Be Caused and Transferred by CD41gens but can nevertheless induce autoimmune diabe-
T Cells Expressing a Single TCRtes when the relevant protein is expressed in pancre-
In a transgenic model of autoimmune diabetes, double-atic tissue. Such diabetogenic T cells are absent,
transgenic mice that express a TCR specific for peptidehowever, among T cells expressing the autospecific
111±119 of influenza hemagglutinin (TCR-HA) and at theTCR as the sole receptor.
same time express the hemagglutinin under control of
the rat insulin promoter (INS-HA), insulitis and diabetes
Introduction
develop spontaneously, as previously described (Saru-
khan et al., 1998). In brief, insulitis was present in all
Genes encoding antigen receptors of lymphocytes are mice at 2 weeks after birth, and diabetes developed
subject to allelic exclusion, with the notable exception from 4 weeks onward. The development of diabetes
of T cell receptor (TCR) a genes: while immunoglobulin could be accelerated by treatment with cyclophospha-
(Ig) heavy (H) chain, Ig light (L) chain, as well as TCRb mide. This was also true in double-transgenic (TCR-HA,
gene segments begin to rearrange on one chromosome INS-HA) mice on the Rag2/2 background, which without
and continue on the other only if the first attempt yielded such treatment developed massive insulitis but devel-
nonproductive genes (Ritchie et al., 1984; Storb et al., oped diabetes infrequently (Sarukhan et al., 1998).
1986; Uematsu et al., 1988; Casanova et al., 1991; Ai- As shown in Table 1, diabetes was observed within 9
fantis et al., 1997), TCRa rearrangements proceed simul- days after transfer of 107 spleen cells from either TCR-
taneously on both chromosomes and are not halted by HA, INS-HA double-transgenic, or TCR-HA single-trans-
productive TCRa genes unless the TCRab binds to a genic mice into immunodeficient INS-HA mice on the
specific ligand (Marolleau et al., 1988; von Boehmer Rag2/2 background. Spleen cells from normal mice did
1990; Borgulya et al., 1992). As a consequence, about not cause diabetes, whereas as few as 104 T cells from
30% of ab T cells contain two productive TCRa alleles single-transgenic TCR-HA mice on the Rag2/2 back-
(Casanova et al., 1991) and thus can express two distinct ground were sufficient for development of diabetes in
ab TCRs that share the same b chain (Marolleau et al., INS-HA Rag2/2 mice (Table 1). In the TCR-HA transgenic
1988; von Boehmer, 1990; Heath and Miller, 1993; Heath strain on the Rag2/2 background, both CD41 as well as
et al., 1995; Padovan et al., 1993). Because of competi- CD81 T cells can express the class II MHC±restricted
tion and preferences of different TCRa chains for a given transgenic TCR (Kirberg et al., 1995). However, CD41
TCRb chain (Saito et al., 1989; Vacchio et al., 1993), T cells were much more potent than CD81 T cells in
mature ab cells can express varying ratios of the two transferring disease (data not shown). These data indi-
different TCRs on the cell surface. cate that the diabetogenic potential of CD41 T cells with
It has been proposed that theexpression of two differ- a single TCR can be revealed by this sensitive transfer
ent TCRs by the same T cell could represent an autoim- assay.
mune hazard: such a cell could be activated through
one receptor's recognition of exogenous antigen pre- Insulitis and Mild Diabetes Develop in TCR-HA,
sented by antigen-presenting cells (APCs) that can effi- INS-HA, IG-HA Triple-Transgenic Mice
ciently activate T cells because of their expression of Despite Massive Central Deletion
costimulatory molecules. The activated cell could then of TCR-HA±Expressing T Cells
As reported previously (Lanoue et al., 1997), massive
deletion of TCR-HA±expressing cells occurred in TCR-*To whom correspondence should be addressed (e-mail: von
boehm@infobiogen.fr). HA transgenic mice that also express hemagglutinin on
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Table 1. Transfer of TCR-HA Cells into INS-HA, Rag2/2 Recipients
Day of Diabetes Onset
Donor Mouse Number of Transferred Cells Diabetic Recipients (mean 6 SD)
BALB/c 107 total splenocytes 0/5 Ð
TCR-HA, INS-HA diabetic 107 total splenocytes 7/7 8.1 6 1.5
TCR-HA, INS-HA nondiabetic 107 total splenocytes 4/4 9.5 6 1.0
TCR-HA 107 total splenocytes 4/4 8.0 6 1.1
TCR-HA, Rag2/2 107 lymph node cells 2/2 7.0 6 0
106 lymph node cells 3/3 8.3 6 0.5
105 lymph node cells 10/10 9.0 6 0.2
104 lymph node cells 5/5 13.0 6 2.0
105 CD41 sorted cells 2/2 10.0 6 0
hemopoietic cells under control of the Igk promoter (IG- to find that in TCR-HA, INS-HA, IG-HA triple-transgenic
mice, the pancreatic tissue was still infiltrated withHA). Nevertheless, some TCR-HA±expressing cells could
be detected in peripheral lymphoid tissue. However, mononuclear cells though less severely than in TCR-
HA, INS-HA double-transgenic mice (Figure 1) and that,these cells were anergic when tested in in vitro assays
for antigen-induced proliferation (Lanoue et al., 1997) as in the latter, cells with the transgenic TCR (detected
by the clonotypic antibody 6.5) were clearly enriched inand, as documented more recently, could produce large
amounts of interleukin-10 (Buer et al., 1998). Thus, these the pancreas (Figure 2). In the triple-transgenic mice,
TCR-HA cells were detected in the spleen (Figure 2) but,results showed that in TCR-HA, IG-HA double-trans-
genic mice, tolerance to HA was established by central as in TCR-HA, IG-HA double-transgenic mice, they were
ªanergicº in terms of in vitro proliferation (data notdeletion of HA-specific T cells as well as by ªanergyº in
peripheral HA-specific T cells that was associated with shown). Thus, despite central deletion (Figure 2) and
ªanergy,º there were still antigen-reactive TCR-HA cellsthe secretion of the immunosuppressive cytokine in-
terleukin-10. in the triple-transgenic mice that could infiltrate the pan-
creas. Mild diabetes developed spontaneously in twoConsidering these data on tolerance, it was surprising
Figure 1. Pancreatic Infiltration in the Various Transgenic Mice
Pancreatic sections from a TCR-HA single-transgenic mouse, a TCR-HA, INS-HA double-transgenic mouse, and a TCR-HA, INS-HA, IG-HA
triple-transgenic mouse. Sections were stained with hematoxylin±eosin (H/E) or stained with CD4 or CD8 antibodies and revealed with
aminoethyl carbazole. Magnification, 1603 or 2003 (left middle and left bottom).
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Figure 2. TCR-HA±Positive Cells in TCR-HA, INS-HA and TCR-HA, INS-HA, IG-HA Transgenic Mice
TCR-HA±positive cells in a TCR-HA, INS-HA, IG-HA triple-transgenic mouse compared to a TCR-HA, INS-HA double-transgenic mouse. The
former was 14 weeks old and the latter was 12 weeks old; neither was diabetic. Total cell numbers (3 106) were 9, 40, 75, and 0.2 in the
thymus (THY), lymph nodes (LN), spleen (SPL), and pancreas (PS), respectively, for the triple-transgenic mouse and 10, 35, 50, and 0.9 for
the double-transgenic mouse. Single-cell suspensions were used for three-color staining with CD4, CD8, and 6.5 antibodies.
of eight triple-transgenic mice at later time points (.13 than that observed upon transfer of cells from TCR-
HA single-transgenic mice (data not shown). To analyzeweeks).
Furthermore, as in TCR-HA, INS-HA double-transgenic which T cells had escaped tolerance induced by HA in
TCR-HA, IG-HA double-transgenic mice, transfer exper-mice, diabetes could be precipitated inall mice by cyclo-
phosphamide administration: a single injection of 200 iments into INS-HA, Rag2/2 mice were performed with
mg/kg cyclophosphamide on day 0 did not induce dia- various T cell populations from TCR-HA, IG-HA double-
betes among TCR-HA single-transgenic mice, whereas transgenic mice. In particular, cells with high levels of
it induced diabetes on day 5 in TCR-HA, INS-HA double- the transgenic TCR residing in spleen and lymph nodes
transgenic mice (two of two) and on day 8 in TCR-HA, and exhibiting signs of activationÐi.e., large size and
INS-HA, IG-HA triple-transgenic mice (two of two). How- CD69 expression (Lanoue et al.,1997)Ðwere transferred
ever, this treatment did not abrogate the unrespon- into INS-HA Rag2/2 recipients. Alternatively, cells with
siveness of splenic TCR-HA T cells in terms of prolifera- low and/or undetectable surface expression of the trans-
tion and did not significantly increase the pancreatic genic TCR were transferred. Surprisingly, in four inde-
infiltration (data not shown). Overall, these data indicate pendent sorting and transfer experiments, the cells with
that the expression of HA by hemopoietic cells caused low levels of the transgenic TCR were more potent in
incomplete tolerance of TCR-HA T cells. causing diabetes than the activated cells with high levels
of the transgenic TCR: the TCR-HAlow cells caused dia-
betes earlier (Table 2) and with more severe histologicalIdentification of Diabetogenic T Cells in TCR-HA,
changes in terms of infiltration and b cell destructionIG-HA Double-Transgenic Mice
Although we had previously found that cells from TCR-
HA, IG-HA mice were ªanergicº in terms of in vitro prolif-
eration, the pancreatic infiltration and cyclophospha- Table 2. Transfer of TCR-HAhigh or TCR-HAlow Cells from TCR-HA,
IG-HA Mice into INS-HA, Rag2/2 Recipientsmide-induced diabetes observed in TCR-HA, INS-HA,
IG-HA triple-transgenic mice suggested that diabeto- Number of Number of Day of Diabetes
genic T cells were still present. The activity of such cells Cells Transferred Mice Diabetic Mice Onset (mean 6 SD)
in TCR-HA, IG-HA double-transgenic mice also could
105 6.5high 8 5a 16.0 6 1.7
be revealed in transfer experiments: transfer of 107 total 105 6.5low 9 9 11.0 6 0.8
splenocytes into INS-HA, Rag2/2 mice induced diabetes
a 3 mice were sacrificed on days 11, 13, and 16 and were not diabeticwithin 9±12 days after transfer (see below), although this
at that time point.
diabetes was less severe in terms of b cell destruction
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Figure 3. Transfer of Diabetes by Splenocytes Expressing Low or High Levels of TCR-HA
Transfer of TCR-HAhigh and TCR-HAlow cells from TCR-HA, IG-HA double-transgenic mice into INS-HA, Rag2/2 recipients. Splenocytes from the
TCR-HA, IG-HA mouse were stained with F23.1 and 6.5 antibodies and sorted according to 6.5 expression, and 105 cells were injected
intravenously into recipient mice. One recipient mouse of TCR-HAlow cells and one recipient mouse of TCR-HAhigh cells were analyzed 13 days
after transfer. The former was diabetic (onset at day 11) and the latter was not. The pancreas of the recipient mice was digested with
collagenase, and infiltrating cells were stained with F23.1, 6.5, and CD3 antibodies.
than the TCR-HAhigh cells (data not shown). When periph- to the production of a second TCR can lead to escape
from tolerance induction and to generation of T cellseral lymphoid tissue and pancreata from mice that had
received TCR-HAlow cells were analyzed, a population able to cause autoimmune disease.
of cells expressing detectable levels of TCR-HA was
clearly found, though these cells expressed, on average, Discussion
lower levels of the transgenic TCR than the cells recov-
ered from the recipients of TCR-HAhigh cells (Figure 3). Experiments in various transgenic mouse models have
shown that spontaneous autoimmune diabetes can be
caused by CD41 T cells recognizing antigens that areComplete Tolerance in CD41 T Cells from TCR-HA,
IG-HA Mice on the Ca2/2 Background expressed in an organ-specific fashion (Katz et al., 1993;
Degermann et al., 1994; Guerder et al., 1994; Scott etThe results described above, demonstrating a higher
diabetogenic potential of TCR-HAlow versus TCR-HAhigh al., 1994; Foerster et al., 1995; Sarukhan et al., 1998).
Some recent data may suggest that this is also true incells from TCR-HA, IG-HA double transgenic mice, sug-
gested that TCR-HAlow cells with some expression of the the human disease (Conrad et al., 1997), although of
course in this case it is much more difficult to demon-transgenic TCR could have escaped tolerance induction
because of higher expression levels of a second TCR strate that a certain antigen and certain T cells are in-
deed the cause of the disease. In the animal modelencoded by transgenic TCRb and endogenous TCRa
chains. If this were the sole reason for escape from that was used in this study, the disease is caused by
a peptide of influenza hemagglutinin expressed as atolerance, one would expect that in TCR-HA, IG-HA
transgenic mice on the Ca2/2 background, which cannot transgene under control of the rat insulin promoter and
recognized by a transgenic TCR (Degermann et al.,produce endogenous TCRa genes, diabetogenic T cells
should be absent. 1994). A thorough analysis of this disease model has
shown that the disease begins with the infiltration of theThis prediction was experimentally confirmed: Ca2/2
TCR-HA, IG-HA mice still containedcells in the periphery pancreas preferentially by T cells with the transgenic
TCR, and that development of diabetes correlates withwith high TCR-HA levels (Figure 4), but these cells did
not cause diabetes even when large numbers of spleno- elevated production of interferon-g but not tumor necro-
sis factor-a by the infiltrating antigen-specific T cellscytes (containing more than 105 TCR-HAhigh cells) were
transferred into INS-HA, Rag2/2 recipients (Table 3). (Sarukhan et al., 1998). In this transgenic model, as in
other transgenic models (AndreÂ et al., 1996) or the NODModerate pancreatic infiltration was observed in some
of the recipients, but diabetes did not develop during model of autoimmune diabetes (Yasunami and Bach,
1988), the development of disease can be acceleratedthe time of observation (30 days after transfer). Thus,
low-level surface expression of an autospecific TCR due by injection of cyclophosphamide, which is supposed
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Figure 4. TCR-HA Cells in TCR-HA, IG-HA Mice Deficient for Ca
TCR-HA±postive cells in the thymus (THY), lymph nodes (LN), and spleen (SPL) of TCR-HA, IG-HA mice on the Ca1 or the Ca2/2 background.
Three-color staining on single-cell suspensions was performed using CD4, CD8, and 6.5 antibodies. Absolute numbers of CD416.51 cells (3
105) in the lymph nodes and spleen were 3.9 and 3.2, respectively, for the Ca1 mouse and 1.4 and 1.3 for the Ca2/2 mouse.
to interfere with regulatory T cells that may prevent the Nevertheless, someT cells with the transgenic TCR were
outbreak of disease. Cyclophosphamide can also in- present in peripheral lymphoid tissue, but by in vitro
duce diabetes in TCR-HA, INS-HA double-transgenic proliferation assays these cells appeared completely
mice on the Rag2/2 background, indicating that T cells anergic although they secreted high levels of the immu-
with a class II±restricted TCR are sufficient to cause nosuppressive cytokine interleukin-10 (Buer etal., 1998).
disease. Diabetes can be transferred into INS-HA mice We were therefore surprised to see that insulitis and,
on the Rag2/2 background by T cells from diabetic and occasionally, mild diabetes still developed in triple-
nondiabetic TCR-HA, INS-HA mice, by T cells from TCR- transgenic TCR-HA, INS-HA, IG-HA mice, indicating that
HA single-transgenic mice even when on the Rag2/2 tolerance to HA was incomplete.
background, but not by T cells from normal mice (Table Even more surprising was the finding that the transfer
1) or INS-HA mice (data not shown). This is by far the of diabetes was more efficient, by the criteria of time of
most sensitive assay to reveal the diabetogenic poten- onset and severity of infiltration, with cells expressing
tial of T cells. low levels of the transgenic TCR than with high TCR-
In a different set of experiments we had noted pre- HA±expressing cells in four independent sorting and
viously that HA expressed as a transgene under the transfer experiments. In both types of injected mice,
control of the Igk promoter caused central deletion of cells with relatively high TCR-HA levels could be de-
TCR-HA T cells, as evident by the almost complete ab- tected in the pancreas, even though the average TCR-
sence of TCR-HA CD41 T cells in the thymi of TCR- HA level was lower in the mice injected with TCR-HAlow
HA, IG-HA double-transgenic mice (Lanoue et al., 1997). cells. That TCR-HAlow cells were significantly stronger
in their diabetogenic potential than TCR-HAhigh cells
Table 3. Transfer of Diabetes by Cells from Ca-Competent and (whereas cells lacking the transgenic TCR were not dia-
Ca-Deficient TCR-HA, IG-HA Mice betogenic) suggested that escape from tolerance could
have been caused by lower surface levels of the trans-Diabetic Day of Diabetes Onset
Donor Mouse Recipients (mean 6 SD) genic TCR due to endogenous TCRa rearrangement and
thereby coexpression of another TCR. This interpreta-TCR-HA, INS-HA 8/9 12.7 6 3.0
tion is consistent with the expression by TCR-HAlow cellsCa2/2, TCR-HA, IG-HA 0/8 Ð
of high levels of the transgenic TCRb chain, i.e., theirThese results represent the sum of three independent experiments.
clear expression of two different TCRs. It is possibleIn each experiment, the Ca-competent and Ca-deficient mice were
that the weak diabetogenic potential of the TCR-HAhighlittermates. The number of total spleen or lymph node cells neces-
sary to transfer the equivalent of 104 (first experiment) or105 (second cells was entirely dependent on a few contaminating
and third experiments)CD416.51 cells from both typesof donor mice TCR-HAlow cells in this population. The suspicion that
was calculated and the cells injected into Rag2/2 INS-HA recipients.
low TCR-HA levels were responsible for escape from
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tolerance was in fact confirmed in Ca2/2 TCR-HA, IG- and could observe some weak peptide-specific stimula-
tion in vitro that was one order of magnitude lower thanHA mice that did contain TCR-HAhigh cells but did not
contain T cells causing diabetes upon transfer into INS- that observed with T cells from single TCR-HA trans-
genic mice. Another possibility is that cells with lowHA recipient mice on the Rag2/2 background. Thus,
these data provide clues about the ways in which T levels of the TCR-HA are continuously activated and
produce some cytokines that cause damage to b isletcells can escape complete tolerance induction to self-
antigens even when these are ubiquitously expressed cells when these cells happen to enter the pancreas.
We also cannot rule out the possibility that surface levelsin the hemopoietic system. The existence of T cells ex-
pressing low surface levels of the HA-specific TCR to- of the relevant TCR can change due to unknown influ-
ences. In this context, it is useful to reiterate that recentgether with higher levels of another TCR was not the
result of ªselective pressureº exerted by the IG-HA, data suggest that continuous specific TCR±ligand inter-
actions are necessary for the survival of T cells in periph-since TCR-HAlow cells from TCR-HA single-transgenic
mice were equally capable of transferring diabetes (data eral lymphoid tissue (Kirberg et al., 1997; Tanchot et al.,
1997). This may cause variation in TCR levels dependingnot shown).
The possibility that escape from tolerance and re- on the costimulatory factors that are present in a certain
milieu. Whatever the precise mechanism(s), the resultssulting autoimmunity may involve allelic inclusion of
TCRa genes also was considered but was not estab- here show that the surface level of an autospecific TCR
that can be regulated by a second TCR of the same celllished in two different transgenic models. In mice ex-
pressing a transgenic TCR specific for a blood-borne plays an important role in self±nonself discrimination.
Thus, negative selection, while effective for many auto-protein (C5), in vitro but not in vivo reactivity to C5 was
detected only in transgenic mice that were not on the reactive T cells, may occasionally fail as a result of TCRa
allelic inclusion, and such failure may represent one ofRag2/2 background (Zal et al., 1994). Furthermore, there
was no evidence that the in vitro response was due to the earliest events in the development of autoimmune
disease.cells expressing low levels of the transgenic TCR. In
another transgenic animal model of rheumatoid arthritis, Finally, one may wonder whether these data, obtained
in transgenic mice, are relevant with regard to factorsit was suspected that T cells overtly reactive to class
II MHC molecules on hemopoietic cells could escape that may determine susceptibility to autoimmune dis-
ease in normal animals. It is clear that escape from self-tolerance and cause severe disease because they ex-
pressed additional receptors (Kouskoff et al., 1996). Our tolerance is required for initiating autoimmune disease
and that TCRa allelic inclusion, which occurs in 30% ofdata pinpoint TCRa allelic inclusion as one cause of
escape from self-tolerance: the TCR-HAhigh cells in TCR- T cells from normal mice, is one mechanism that can
account for such an escape even when the antigen is,HA, IG-HA Ca2/2 mice looked by all criteria like the TCR-
HAhigh cells in the TCR-HA, IG-HA mice: they were large in addition to its organ-specific expression, ubiquitously
present on hemopoietic cells. A situation very similar toand exhibited activation markers such as CD69. This
then means that these cells are not diabetogenic and that of our transgenic model may in fact exist in normal
mice, in which organ-specific proteins are taken up andthat only cells with low levels of the transgenic TCR are
diabetogenic. TCR-HA±negative cells are also present processed by mobile APCs that can then induce toler-
ance in T cells with high levels of the relevant TCR.in the Ca2/2 mice, but these cells express endogenous
TCRb chains. Cells with endogenous TCRb chains have In addition, it has been shown that antigens can be
expressed specifically in thepancreas and in the thymuspreviously been noted in abTCR transgenic mice under
conditions in which cells with the transgenic TCR are and nowhere else (Jolicoeur et al., 1994; Smith et al.,
1997). Again, escape form self-tolerance in the thymusnegatively selected. It was shown that these cells had
lost the TCRb transgene (BluÈ thmann et al., 1988). It ap- by the mechanism described here could be relevant for
the initiation of autoimmune disease. Thus, the experi-pears unlikely that these TCR-HA±negative cells silence
the diabetogenic T cells since T cells with nontransgenic mental situation described here is not entirely artificial
and may have its counterpart in normal mice. Autoim-TCRs are likewise present in TCR-HA, IG-HA mice.
The precise mechanism by which TCR-HAlow cells mune diseases are usually under complex genetic regu-
lation, but all require escape from self-tolerance. Herecause diabetes is presently not clear. Several possibili-
ties can be considered in the context of the reported we describe one particular mechanism by which such
data: the concentration of the relevant peptide on hemo- an escape is made possible.
poietic cells in primary as well as secondary lymphoid
organs may be sufficient only to delete or anergize high-
Experimental Proceduresavidity cells with higher surface levels of the relevant
receptor, while cells with lower levels may survive. Such Mice
cells failing to receive strongly activating signals may TCR-HA transgenic mice expressing a TCRab specific for peptide
nevertheless home to the pancreas, where they may be 111±119 from influenza HA presented by I-Ed have been described
previously (Kirberg et al., 1995; Lanoue et al., 1997). Mice expressingstimulated by professional APCs that efficiently present
HA on hemopoietic cells (IG-HA) have the HA transgene under con-the peptide derived from proteins expressed in b islet
trol of the Igk promoter and enhancer elements and are on thecells. If so, then among TCR-HAlow cells from TCR-HA,
BALB/c background (Lanoue et al., 1997). INS-HA mice, previously
IG-HA double-transgenic mice, it should be possible to described (Lo et al., 1992), express the hemagglutinin under the rat
select cells in vitro with the help of professional APCs insulin promoter and are on the BALB/c background. TCR-HA mice
such as dendritic cells presenting high levels of the were crossed with IG-HA mice and INS-HA mice in our animal facili-
ties. The presence of transgenes in offspring was determined byrelevant peptide. We have attempted such experiments
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polymerase chain reaction, and the INS-HA and IG-HA transgenes de la SanteÂ et Recherche MeÂ dicale, Paris, and the FaculteÂ Necker
Enfants Malades, Descartes UniversiteÂ , Paris.were differentiated by Southern blot. INS-HA, Rag2/2 mice have
been described previously (Sarukhan et al., 1998). Ca2/2 mice on
the BALB/c background (kindly provided by N. Glaichenhaus, Nice, Received March 9, 1998.
France) were crossed and backcrossed with TCR-HA and IG-HA
mice to obtain Ca2/2 TCR-HA, IG-HA mice. Homozygosity for the
ReferencesCa deletion was determined by staining peripheral blood lympho-
cytes with F23.1 and 6.5 antibodies.
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